Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sinusitis | 86 | 2024 | 995 | 14.780 |
Why?
|
Rhinitis | 70 | 2024 | 751 | 13.520 |
Why?
|
Ambulatory Surgical Procedures | 19 | 2019 | 470 | 5.480 |
Why?
|
Tonsillectomy | 17 | 2019 | 280 | 5.290 |
Why?
|
Endoscopy | 34 | 2024 | 1857 | 4.180 |
Why?
|
Otolaryngology | 23 | 2024 | 701 | 4.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 15 | 2018 | 326 | 3.670 |
Why?
|
Nasal Polyps | 22 | 2025 | 409 | 3.660 |
Why?
|
Paranasal Sinuses | 22 | 2018 | 266 | 3.190 |
Why?
|
Otitis Media | 7 | 2020 | 288 | 2.760 |
Why?
|
Head and Neck Neoplasms | 19 | 2020 | 2923 | 2.690 |
Why?
|
Otorhinolaryngologic Diseases | 5 | 2024 | 97 | 2.250 |
Why?
|
Chronic Disease | 72 | 2024 | 9379 | 2.210 |
Why?
|
Office Visits | 10 | 2021 | 596 | 2.170 |
Why?
|
Cross-Sectional Studies | 78 | 2023 | 26375 | 2.140 |
Why?
|
Dizziness | 6 | 2019 | 269 | 2.110 |
Why?
|
Patient Readmission | 11 | 2019 | 3312 | 1.970 |
Why?
|
Ambulatory Care | 9 | 2021 | 2784 | 1.930 |
Why?
|
Postoperative Complications | 26 | 2019 | 15881 | 1.790 |
Why?
|
Postural Balance | 5 | 2019 | 639 | 1.740 |
Why?
|
Carcinoma, Squamous Cell | 21 | 2017 | 4069 | 1.660 |
Why?
|
United States | 94 | 2024 | 73150 | 1.610 |
Why?
|
Voice Disorders | 4 | 2024 | 286 | 1.570 |
Why?
|
Rhinoplasty | 4 | 2022 | 241 | 1.530 |
Why?
|
Adenoidectomy | 6 | 2016 | 170 | 1.520 |
Why?
|
Laryngeal Neoplasms | 4 | 2021 | 515 | 1.460 |
Why?
|
Rhinitis, Allergic, Seasonal | 5 | 2012 | 104 | 1.440 |
Why?
|
Cost of Illness | 9 | 2020 | 1959 | 1.430 |
Why?
|
Regional Medical Programs | 3 | 2016 | 66 | 1.410 |
Why?
|
Paranasal Sinus Diseases | 5 | 2016 | 121 | 1.400 |
Why?
|
Postoperative Hemorrhage | 6 | 2015 | 419 | 1.390 |
Why?
|
Hearing Loss | 4 | 2021 | 786 | 1.380 |
Why?
|
SEER Program | 18 | 2019 | 1474 | 1.370 |
Why?
|
Anti-Anxiety Agents | 2 | 2023 | 405 | 1.360 |
Why?
|
Male | 204 | 2024 | 364902 | 1.340 |
Why?
|
Health Care Costs | 8 | 2021 | 3267 | 1.320 |
Why?
|
Female | 207 | 2025 | 397089 | 1.270 |
Why?
|
Prevalence | 34 | 2024 | 15872 | 1.250 |
Why?
|
Humans | 295 | 2025 | 768393 | 1.230 |
Why?
|
Middle Ear Ventilation | 2 | 2020 | 101 | 1.230 |
Why?
|
Ear Protective Devices | 2 | 2019 | 10 | 1.230 |
Why?
|
Adrenal Cortex Hormones | 5 | 2024 | 1890 | 1.170 |
Why?
|
Palatine Tonsil | 3 | 2019 | 193 | 1.170 |
Why?
|
Olfaction Disorders | 3 | 2023 | 226 | 1.160 |
Why?
|
Adult | 133 | 2024 | 223640 | 1.110 |
Why?
|
Carcinoma, Papillary | 6 | 2010 | 793 | 1.100 |
Why?
|
Deglutition Disorders | 6 | 2014 | 641 | 1.100 |
Why?
|
Health Care Surveys | 6 | 2021 | 2437 | 1.080 |
Why?
|
Anti-Bacterial Agents | 17 | 2024 | 7463 | 1.080 |
Why?
|
Middle Aged | 128 | 2024 | 223491 | 1.030 |
Why?
|
Accidents | 2 | 2018 | 164 | 1.030 |
Why?
|
Neoplasms, Second Primary | 6 | 2019 | 1060 | 1.010 |
Why?
|
Sleep Apnea, Obstructive | 5 | 2023 | 1891 | 1.000 |
Why?
|
Rhinitis, Allergic, Perennial | 3 | 2012 | 60 | 0.990 |
Why?
|
Health Expenditures | 7 | 2021 | 2395 | 0.990 |
Why?
|
Thyroid Diseases | 3 | 2015 | 387 | 0.970 |
Why?
|
Vertigo | 3 | 2019 | 205 | 0.960 |
Why?
|
Wounds and Injuries | 5 | 2018 | 2514 | 0.950 |
Why?
|
Hospitals, Teaching | 5 | 2016 | 1158 | 0.940 |
Why?
|
Thyroid Neoplasms | 10 | 2020 | 2360 | 0.930 |
Why?
|
Income | 3 | 2022 | 1877 | 0.920 |
Why?
|
Retrospective Studies | 65 | 2024 | 81801 | 0.910 |
Why?
|
Ageusia | 1 | 2023 | 18 | 0.870 |
Why?
|
Administration, Topical | 2 | 2024 | 703 | 0.870 |
Why?
|
Epistaxis | 3 | 2017 | 117 | 0.860 |
Why?
|
Health Surveys | 11 | 2024 | 4056 | 0.850 |
Why?
|
Budesonide | 1 | 2024 | 162 | 0.840 |
Why?
|
Adenocarcinoma, Follicular | 4 | 2010 | 326 | 0.820 |
Why?
|
Activities of Daily Living | 3 | 2022 | 2433 | 0.820 |
Why?
|
Databases, Factual | 19 | 2019 | 8075 | 0.820 |
Why?
|
Semicircular Canals | 1 | 2024 | 203 | 0.810 |
Why?
|
Authorship | 5 | 2012 | 289 | 0.800 |
Why?
|
Age Distribution | 12 | 2020 | 2877 | 0.800 |
Why?
|
Asthma | 6 | 2023 | 6280 | 0.800 |
Why?
|
Insurance Coverage | 5 | 2021 | 1946 | 0.800 |
Why?
|
Outpatients | 5 | 2021 | 1604 | 0.790 |
Why?
|
Vocal Cord Paralysis | 5 | 2009 | 275 | 0.790 |
Why?
|
Emergency Service, Hospital | 9 | 2021 | 7955 | 0.790 |
Why?
|
Incidence | 28 | 2020 | 21544 | 0.780 |
Why?
|
Sensation Disorders | 2 | 2013 | 160 | 0.770 |
Why?
|
Ethmoid Sinus | 6 | 2012 | 58 | 0.750 |
Why?
|
Nasal Septum | 4 | 2007 | 131 | 0.750 |
Why?
|
Depressive Disorder | 4 | 2024 | 3736 | 0.750 |
Why?
|
Tomography, X-Ray Computed | 27 | 2024 | 20765 | 0.730 |
Why?
|
Paranasal Sinus Neoplasms | 5 | 2009 | 243 | 0.730 |
Why?
|
Otitis | 2 | 2010 | 21 | 0.710 |
Why?
|
Tonsillitis | 4 | 2007 | 28 | 0.700 |
Why?
|
Dysphonia | 1 | 2023 | 144 | 0.700 |
Why?
|
Child | 50 | 2022 | 80891 | 0.690 |
Why?
|
Nasal Cavity | 5 | 2010 | 311 | 0.690 |
Why?
|
Taste Disorders | 2 | 2023 | 38 | 0.690 |
Why?
|
Glottis | 3 | 2019 | 214 | 0.690 |
Why?
|
Snoring | 2 | 2015 | 211 | 0.690 |
Why?
|
Asthma, Aspirin-Induced | 6 | 2023 | 204 | 0.680 |
Why?
|
Frontal Sinusitis | 2 | 2012 | 19 | 0.670 |
Why?
|
Sex Distribution | 10 | 2018 | 2281 | 0.660 |
Why?
|
Electrosurgery | 1 | 2019 | 53 | 0.650 |
Why?
|
Hearing Disorders | 2 | 2018 | 126 | 0.640 |
Why?
|
Vestibule, Labyrinth | 2 | 2019 | 235 | 0.640 |
Why?
|
Nutrition Surveys | 3 | 2022 | 1736 | 0.640 |
Why?
|
Publishing | 5 | 2012 | 836 | 0.640 |
Why?
|
Neoplasm Staging | 20 | 2019 | 11254 | 0.640 |
Why?
|
Carcinoma, Mucoepidermoid | 4 | 2007 | 91 | 0.630 |
Why?
|
Diagnostic Techniques, Otological | 1 | 2018 | 11 | 0.630 |
Why?
|
Postoperative Care | 6 | 2024 | 1480 | 0.630 |
Why?
|
Case-Control Studies | 20 | 2023 | 22296 | 0.620 |
Why?
|
Patient Acceptance of Health Care | 4 | 2021 | 3231 | 0.620 |
Why?
|
Maxillary Sinus Neoplasms | 3 | 2003 | 38 | 0.620 |
Why?
|
Salivary Gland Neoplasms | 3 | 2010 | 306 | 0.620 |
Why?
|
Severity of Illness Index | 23 | 2019 | 15939 | 0.610 |
Why?
|
Tinnitus | 3 | 2016 | 197 | 0.610 |
Why?
|
Anti-Asthmatic Agents | 1 | 2023 | 577 | 0.600 |
Why?
|
Mortality | 2 | 2020 | 2917 | 0.600 |
Why?
|
Pharyngeal Diseases | 2 | 2019 | 134 | 0.600 |
Why?
|
Erectile Dysfunction | 1 | 2021 | 445 | 0.600 |
Why?
|
Otologic Surgical Procedures | 1 | 2019 | 150 | 0.600 |
Why?
|
Tracheotomy | 2 | 2017 | 168 | 0.590 |
Why?
|
Rhytidoplasty | 1 | 2018 | 72 | 0.580 |
Why?
|
Acute Disease | 12 | 2024 | 7242 | 0.570 |
Why?
|
Mouth Neoplasms | 2 | 2017 | 597 | 0.570 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2019 | 144 | 0.570 |
Why?
|
Steroids | 6 | 2011 | 937 | 0.570 |
Why?
|
Absenteeism | 5 | 2016 | 247 | 0.570 |
Why?
|
Noise, Occupational | 1 | 2017 | 26 | 0.570 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3743 | 0.560 |
Why?
|
Deafness | 1 | 2021 | 462 | 0.560 |
Why?
|
Carcinoma, Verrucous | 1 | 2017 | 26 | 0.550 |
Why?
|
Thyroidectomy | 4 | 2015 | 914 | 0.550 |
Why?
|
Parotid Neoplasms | 4 | 2007 | 158 | 0.550 |
Why?
|
Survival Rate | 18 | 2019 | 12870 | 0.550 |
Why?
|
Insurance, Health | 5 | 2021 | 2518 | 0.540 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2019 | 1794 | 0.540 |
Why?
|
Aged | 60 | 2024 | 171562 | 0.540 |
Why?
|
Accidental Falls | 2 | 2015 | 1080 | 0.530 |
Why?
|
Child, Preschool | 29 | 2021 | 42650 | 0.530 |
Why?
|
Population Surveillance | 6 | 2014 | 2598 | 0.530 |
Why?
|
Adolescent | 44 | 2024 | 89184 | 0.530 |
Why?
|
Quality of Life | 15 | 2022 | 13503 | 0.530 |
Why?
|
Ambulatory Care Facilities | 2 | 2019 | 941 | 0.530 |
Why?
|
Laryngoscopy | 3 | 2015 | 714 | 0.530 |
Why?
|
Healthcare Disparities | 3 | 2018 | 3413 | 0.520 |
Why?
|
Odds Ratio | 12 | 2024 | 9682 | 0.520 |
Why?
|
Carcinoma, Adenoid Cystic | 5 | 2005 | 264 | 0.520 |
Why?
|
Football | 1 | 2022 | 506 | 0.510 |
Why?
|
Laryngeal Masks | 2 | 2009 | 118 | 0.510 |
Why?
|
Drug Utilization | 3 | 2018 | 1191 | 0.510 |
Why?
|
Hearing Tests | 1 | 2016 | 123 | 0.510 |
Why?
|
Follow-Up Studies | 31 | 2019 | 39407 | 0.510 |
Why?
|
Ethmoid Sinusitis | 2 | 2012 | 25 | 0.510 |
Why?
|
Nose Diseases | 2 | 2010 | 79 | 0.500 |
Why?
|
Florida | 4 | 2018 | 430 | 0.500 |
Why?
|
Tissue and Organ Harvesting | 1 | 2018 | 374 | 0.500 |
Why?
|
Palatal Neoplasms | 2 | 2009 | 37 | 0.480 |
Why?
|
Risk Assessment | 17 | 2018 | 24318 | 0.480 |
Why?
|
New York | 4 | 2018 | 884 | 0.460 |
Why?
|
Foreign Bodies | 2 | 2014 | 403 | 0.460 |
Why?
|
Child, Hospitalized | 1 | 2016 | 182 | 0.460 |
Why?
|
Patient Positioning | 1 | 2017 | 332 | 0.460 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 166 | 0.440 |
Why?
|
Hospitalization | 5 | 2016 | 10844 | 0.440 |
Why?
|
Nasal Mucosa | 4 | 2021 | 411 | 0.440 |
Why?
|
Frontal Sinus | 4 | 2012 | 51 | 0.440 |
Why?
|
Academic Medical Centers | 3 | 2016 | 2783 | 0.440 |
Why?
|
Nose Neoplasms | 4 | 2007 | 250 | 0.440 |
Why?
|
Reoperation | 4 | 2018 | 4341 | 0.440 |
Why?
|
Socioeconomic Factors | 10 | 2018 | 7861 | 0.430 |
Why?
|
Intraoperative Complications | 3 | 2010 | 1176 | 0.420 |
Why?
|
Firearms | 2 | 2019 | 632 | 0.420 |
Why?
|
Survival Analysis | 17 | 2011 | 10117 | 0.420 |
Why?
|
Eosinophils | 4 | 2007 | 953 | 0.410 |
Why?
|
Behavior, Addictive | 1 | 2018 | 433 | 0.410 |
Why?
|
Sphenoid Sinus | 3 | 2005 | 101 | 0.410 |
Why?
|
Iowa | 3 | 2018 | 101 | 0.400 |
Why?
|
Prospective Studies | 37 | 2023 | 54920 | 0.400 |
Why?
|
Drug Prescriptions | 2 | 2020 | 1673 | 0.400 |
Why?
|
Laryngeal Diseases | 1 | 2015 | 248 | 0.400 |
Why?
|
Obesity | 5 | 2015 | 13084 | 0.400 |
Why?
|
Eosinophilia | 5 | 2015 | 556 | 0.390 |
Why?
|
Nebulizers and Vaporizers | 2 | 2023 | 139 | 0.390 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 424 | 0.390 |
Why?
|
Employment | 2 | 2022 | 1116 | 0.390 |
Why?
|
Health Status Disparities | 2 | 2016 | 1882 | 0.390 |
Why?
|
Anxiety Disorders | 4 | 2024 | 2754 | 0.390 |
Why?
|
Facial Bones | 2 | 2011 | 209 | 0.380 |
Why?
|
Guideline Adherence | 2 | 2013 | 2240 | 0.380 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2004 | 342 | 0.380 |
Why?
|
Otitis Externa | 1 | 2011 | 17 | 0.380 |
Why?
|
Athletic Injuries | 1 | 2022 | 1245 | 0.380 |
Why?
|
Chi-Square Distribution | 8 | 2011 | 3438 | 0.370 |
Why?
|
Pain, Postoperative | 4 | 2015 | 1765 | 0.370 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2011 | 617 | 0.370 |
Why?
|
Tobacco, Smokeless | 1 | 2012 | 133 | 0.370 |
Why?
|
Comorbidity | 7 | 2023 | 10588 | 0.370 |
Why?
|
Inpatients | 2 | 2014 | 2570 | 0.370 |
Why?
|
Infant | 18 | 2021 | 36510 | 0.360 |
Why?
|
Work | 1 | 2012 | 195 | 0.360 |
Why?
|
Salivary Glands, Minor | 1 | 2010 | 27 | 0.360 |
Why?
|
Risk Factors | 23 | 2023 | 74962 | 0.360 |
Why?
|
Bronchi | 1 | 2014 | 849 | 0.350 |
Why?
|
Lymphatic Metastasis | 5 | 2009 | 2925 | 0.350 |
Why?
|
Catheterization | 1 | 2016 | 1431 | 0.350 |
Why?
|
Brain Concussion | 1 | 2022 | 1433 | 0.350 |
Why?
|
Airway Obstruction | 2 | 2009 | 672 | 0.350 |
Why?
|
Viral Matrix Proteins | 1 | 2011 | 193 | 0.350 |
Why?
|
Proportional Hazards Models | 14 | 2020 | 12558 | 0.350 |
Why?
|
Global Warming | 1 | 2011 | 79 | 0.350 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 390 | 0.340 |
Why?
|
Fatigue | 2 | 2008 | 1555 | 0.340 |
Why?
|
Periodicals as Topic | 4 | 2009 | 1469 | 0.340 |
Why?
|
Physician Assistants | 1 | 2012 | 190 | 0.330 |
Why?
|
Length of Stay | 8 | 2018 | 6519 | 0.330 |
Why?
|
Neck Dissection | 2 | 2003 | 201 | 0.330 |
Why?
|
Orthopedic Procedures | 2 | 2011 | 1280 | 0.330 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2010 | 59 | 0.330 |
Why?
|
Operating Rooms | 2 | 2007 | 799 | 0.330 |
Why?
|
Ear Diseases | 1 | 2011 | 181 | 0.330 |
Why?
|
Benchmarking | 2 | 2016 | 1058 | 0.320 |
Why?
|
Diagnosis, Differential | 10 | 2024 | 13020 | 0.320 |
Why?
|
Recurrence | 11 | 2018 | 8506 | 0.320 |
Why?
|
Patient Discharge | 2 | 2019 | 3476 | 0.320 |
Why?
|
Nose | 1 | 2013 | 523 | 0.320 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2006 | 555 | 0.320 |
Why?
|
Palate, Hard | 1 | 2009 | 59 | 0.320 |
Why?
|
Pharyngitis | 1 | 2010 | 222 | 0.320 |
Why?
|
Histamine H1 Antagonists | 5 | 2007 | 101 | 0.310 |
Why?
|
Prognosis | 18 | 2014 | 30022 | 0.310 |
Why?
|
Carcinoma, Acinar Cell | 2 | 2006 | 62 | 0.310 |
Why?
|
Treatment Outcome | 27 | 2024 | 65379 | 0.310 |
Why?
|
Health Services for the Aged | 1 | 2011 | 258 | 0.310 |
Why?
|
Alcohol Drinking | 3 | 2018 | 4049 | 0.310 |
Why?
|
Otorhinolaryngologic Neoplasms | 2 | 1998 | 26 | 0.310 |
Why?
|
Sex Factors | 9 | 2019 | 10654 | 0.310 |
Why?
|
Practice Guidelines as Topic | 5 | 2017 | 7453 | 0.310 |
Why?
|
Hospital Costs | 1 | 2014 | 959 | 0.310 |
Why?
|
Patient Admission | 1 | 2016 | 1367 | 0.310 |
Why?
|
Administration, Oral | 4 | 2024 | 4039 | 0.300 |
Why?
|
Workload | 2 | 2011 | 852 | 0.300 |
Why?
|
Mycoses | 2 | 2009 | 386 | 0.300 |
Why?
|
California | 3 | 2018 | 1443 | 0.300 |
Why?
|
Time Factors | 15 | 2019 | 40272 | 0.290 |
Why?
|
Hearing | 2 | 2022 | 502 | 0.290 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2188 | 0.290 |
Why?
|
Thyroid Cartilage | 2 | 2009 | 46 | 0.290 |
Why?
|
Organ Transplantation | 2 | 2011 | 1177 | 0.290 |
Why?
|
Hypocalcemia | 2 | 2015 | 203 | 0.280 |
Why?
|
Operating Room Information Systems | 1 | 2007 | 15 | 0.280 |
Why?
|
Rhabdomyosarcoma | 2 | 2009 | 358 | 0.280 |
Why?
|
Respiratory Tract Diseases | 2 | 2010 | 748 | 0.280 |
Why?
|
Esophageal Sphincter, Upper | 1 | 2007 | 11 | 0.280 |
Why?
|
Pneumocephalus | 1 | 2007 | 46 | 0.280 |
Why?
|
Physicians, Women | 2 | 2012 | 520 | 0.280 |
Why?
|
Academies and Institutes | 1 | 2009 | 326 | 0.280 |
Why?
|
Drug Resistance, Microbial | 2 | 2008 | 830 | 0.280 |
Why?
|
Postoperative Period | 5 | 2018 | 1830 | 0.280 |
Why?
|
Zenker Diverticulum | 1 | 2007 | 28 | 0.270 |
Why?
|
Histamine H1 Antagonists, Non-Sedating | 1 | 2006 | 17 | 0.270 |
Why?
|
Laryngismus | 1 | 2006 | 28 | 0.270 |
Why?
|
Iodine Radioisotopes | 2 | 2009 | 1035 | 0.270 |
Why?
|
Occupational Exposure | 1 | 2017 | 1817 | 0.270 |
Why?
|
Lichen Planus, Oral | 1 | 2007 | 57 | 0.270 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1006 | 0.270 |
Why?
|
Risk Management | 1 | 2010 | 558 | 0.270 |
Why?
|
Electrocoagulation | 1 | 2007 | 153 | 0.270 |
Why?
|
Bronchial Spasm | 1 | 2006 | 71 | 0.260 |
Why?
|
Temperature | 2 | 2011 | 2235 | 0.260 |
Why?
|
Sphenoid Sinusitis | 1 | 2005 | 10 | 0.260 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1813 | 0.260 |
Why?
|
Maxilla | 2 | 2009 | 489 | 0.260 |
Why?
|
Health Services | 1 | 2011 | 756 | 0.260 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 3836 | 0.260 |
Why?
|
Parotid Gland | 2 | 2004 | 178 | 0.260 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1082 | 0.250 |
Why?
|
Fiber Optic Technology | 2 | 2004 | 291 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3252 | 0.250 |
Why?
|
Air Pollution | 2 | 2010 | 2363 | 0.250 |
Why?
|
Hospital Mortality | 3 | 2018 | 5367 | 0.250 |
Why?
|
Anti-Inflammatory Agents | 5 | 2024 | 1813 | 0.250 |
Why?
|
Gelatin Sponge, Absorbable | 2 | 2003 | 55 | 0.250 |
Why?
|
Hypersensitivity | 3 | 2024 | 1173 | 0.250 |
Why?
|
Mast Cells | 3 | 2025 | 1407 | 0.250 |
Why?
|
Mass Screening | 2 | 2023 | 5451 | 0.250 |
Why?
|
Anxiety | 3 | 2023 | 4677 | 0.240 |
Why?
|
Nose Deformities, Acquired | 1 | 2005 | 44 | 0.240 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1226 | 0.240 |
Why?
|
Health Facility Size | 2 | 2016 | 61 | 0.240 |
Why?
|
Decision Making | 1 | 2019 | 3953 | 0.240 |
Why?
|
Eye Protective Devices | 1 | 2004 | 33 | 0.240 |
Why?
|
Intubation, Intratracheal | 3 | 2009 | 1359 | 0.240 |
Why?
|
Meige Syndrome | 2 | 2001 | 12 | 0.240 |
Why?
|
Cohort Studies | 16 | 2021 | 41795 | 0.230 |
Why?
|
Turbinates | 2 | 2011 | 66 | 0.230 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2004 | 10 | 0.230 |
Why?
|
Lymphoproliferative Disorders | 2 | 2011 | 529 | 0.230 |
Why?
|
Conflict of Interest | 1 | 2009 | 555 | 0.230 |
Why?
|
Hypertrophy | 3 | 2019 | 562 | 0.230 |
Why?
|
Respiratory Protective Devices | 1 | 2004 | 47 | 0.230 |
Why?
|
Antifungal Agents | 1 | 2009 | 759 | 0.220 |
Why?
|
Probability | 6 | 2006 | 2482 | 0.220 |
Why?
|
Maxillary Sinus | 2 | 2006 | 175 | 0.220 |
Why?
|
Tracheal Neoplasms | 1 | 2004 | 124 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Dysgeusia | 1 | 2023 | 15 | 0.220 |
Why?
|
Anesthesia, Conduction | 1 | 2007 | 263 | 0.220 |
Why?
|
Disclosure | 1 | 2009 | 754 | 0.220 |
Why?
|
Algorithms | 4 | 2019 | 14154 | 0.220 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12092 | 0.220 |
Why?
|
Deglutition | 4 | 2014 | 208 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Adenoids | 1 | 2003 | 35 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3107 | 0.210 |
Why?
|
Bacterial Infections | 3 | 2007 | 1397 | 0.210 |
Why?
|
Confidence Intervals | 4 | 2014 | 2931 | 0.210 |
Why?
|
Logistic Models | 7 | 2016 | 13323 | 0.210 |
Why?
|
Prostheses and Implants | 2 | 2007 | 1279 | 0.210 |
Why?
|
RNA, Viral | 1 | 2011 | 2866 | 0.210 |
Why?
|
Regression Analysis | 6 | 2010 | 6350 | 0.210 |
Why?
|
Tonsillar Neoplasms | 1 | 2003 | 50 | 0.210 |
Why?
|
Preoperative Care | 5 | 2010 | 2258 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.200 |
Why?
|
Combined Modality Therapy | 9 | 2019 | 8562 | 0.200 |
Why?
|
Laryngoscopes | 1 | 2004 | 147 | 0.200 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2004 | 238 | 0.200 |
Why?
|
Keratoconus | 1 | 2024 | 112 | 0.200 |
Why?
|
Depression | 4 | 2023 | 8241 | 0.200 |
Why?
|
Carcinoma, Medullary | 1 | 2003 | 116 | 0.200 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5375 | 0.200 |
Why?
|
Trinucleotide Repeat Expansion | 2 | 2001 | 254 | 0.200 |
Why?
|
Cognition | 1 | 2020 | 7075 | 0.200 |
Why?
|
Disease Management | 1 | 2013 | 2537 | 0.200 |
Why?
|
Disinfection | 1 | 2004 | 207 | 0.200 |
Why?
|
Morbidity | 3 | 2020 | 1758 | 0.200 |
Why?
|
Age Factors | 11 | 2014 | 18471 | 0.200 |
Why?
|
Taste | 1 | 2023 | 190 | 0.200 |
Why?
|
Lymphoma | 2 | 2008 | 1907 | 0.200 |
Why?
|
Mandible | 3 | 2013 | 759 | 0.190 |
Why?
|
Medical Oncology | 1 | 2013 | 2349 | 0.190 |
Why?
|
Meniere Disease | 2 | 2004 | 164 | 0.190 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2001 | 24 | 0.190 |
Why?
|
Epithelial Cells | 4 | 2023 | 3695 | 0.190 |
Why?
|
Pneumonia, Aspiration | 1 | 2002 | 145 | 0.190 |
Why?
|
Microbiology | 1 | 2002 | 70 | 0.190 |
Why?
|
Adenoma, Oxyphilic | 1 | 2003 | 152 | 0.190 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2004 | 290 | 0.190 |
Why?
|
Nasal Obstruction | 2 | 2000 | 163 | 0.180 |
Why?
|
Aspirin | 5 | 2023 | 3135 | 0.180 |
Why?
|
Tongue Neoplasms | 1 | 2003 | 186 | 0.180 |
Why?
|
Smoking | 1 | 2018 | 9111 | 0.180 |
Why?
|
Smell | 1 | 2023 | 261 | 0.180 |
Why?
|
Facial Nerve | 2 | 2004 | 277 | 0.180 |
Why?
|
Aged, 80 and over | 14 | 2018 | 59686 | 0.180 |
Why?
|
Carcinoma | 2 | 2010 | 2341 | 0.180 |
Why?
|
Interleukin-5 Receptor alpha Subunit | 1 | 2020 | 17 | 0.180 |
Why?
|
Tobacco Smoke Pollution | 1 | 2006 | 827 | 0.170 |
Why?
|
Salaries and Fringe Benefits | 1 | 2022 | 262 | 0.170 |
Why?
|
Nerve Block | 1 | 2007 | 716 | 0.170 |
Why?
|
Antibodies, Viral | 1 | 2011 | 3211 | 0.170 |
Why?
|
Infant, Newborn | 7 | 2021 | 26411 | 0.170 |
Why?
|
Drug Resistance, Bacterial | 2 | 2004 | 1063 | 0.170 |
Why?
|
Administration, Inhalation | 1 | 2023 | 1169 | 0.170 |
Why?
|
Stapedius | 1 | 1999 | 26 | 0.170 |
Why?
|
Neck | 2 | 2003 | 736 | 0.170 |
Why?
|
Predictive Value of Tests | 7 | 2012 | 15455 | 0.170 |
Why?
|
Sleep | 1 | 2015 | 4802 | 0.170 |
Why?
|
Medicaid | 3 | 2021 | 2842 | 0.160 |
Why?
|
Fractures, Bone | 1 | 2011 | 2062 | 0.160 |
Why?
|
Botulinum Toxins | 1 | 2001 | 189 | 0.160 |
Why?
|
Adenocarcinoma | 4 | 2005 | 6406 | 0.160 |
Why?
|
Young Adult | 12 | 2024 | 60049 | 0.160 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5512 | 0.160 |
Why?
|
Esophagectomy | 1 | 2003 | 482 | 0.160 |
Why?
|
Maxillary Sinusitis | 1 | 1999 | 41 | 0.160 |
Why?
|
Eye Diseases | 1 | 2024 | 657 | 0.160 |
Why?
|
Kentucky | 1 | 2018 | 84 | 0.160 |
Why?
|
Angioedema | 1 | 2000 | 184 | 0.160 |
Why?
|
Food | 1 | 2003 | 768 | 0.160 |
Why?
|
Medicare | 2 | 2014 | 6881 | 0.160 |
Why?
|
Ear Cartilage | 1 | 2018 | 62 | 0.160 |
Why?
|
Explosions | 1 | 2019 | 107 | 0.150 |
Why?
|
Th2 Cells | 1 | 2024 | 1079 | 0.150 |
Why?
|
Esthesioneuroblastoma, Olfactory | 2 | 2007 | 58 | 0.150 |
Why?
|
Petrous Bone | 1 | 1998 | 85 | 0.150 |
Why?
|
Beverages | 1 | 2003 | 819 | 0.150 |
Why?
|
Women | 1 | 2000 | 226 | 0.150 |
Why?
|
North Carolina | 1 | 2018 | 328 | 0.150 |
Why?
|
Michigan | 1 | 2018 | 341 | 0.150 |
Why?
|
Syndrome | 1 | 2024 | 3275 | 0.150 |
Why?
|
Laser Therapy | 1 | 2004 | 1105 | 0.140 |
Why?
|
Radiography | 4 | 2011 | 6993 | 0.140 |
Why?
|
Hemangiopericytoma | 1 | 1997 | 71 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6541 | 0.140 |
Why?
|
Fluoroscopy | 4 | 2007 | 952 | 0.140 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 1998 | 180 | 0.140 |
Why?
|
Granuloma, Pyogenic | 1 | 1997 | 47 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2025 | 2003 | 0.140 |
Why?
|
Peer Review | 1 | 1999 | 219 | 0.140 |
Why?
|
Demography | 2 | 2011 | 1642 | 0.140 |
Why?
|
Statistics, Nonparametric | 3 | 2010 | 2862 | 0.140 |
Why?
|
Fibrosarcoma | 1 | 1998 | 313 | 0.130 |
Why?
|
Conjunctival Neoplasms | 1 | 1997 | 77 | 0.130 |
Why?
|
Music | 1 | 2019 | 247 | 0.130 |
Why?
|
Surgical Wound Infection | 2 | 2016 | 1545 | 0.130 |
Why?
|
Alveolar Ridge Augmentation | 1 | 1999 | 209 | 0.130 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 1 | 2016 | 48 | 0.130 |
Why?
|
Video Recording | 4 | 2007 | 974 | 0.130 |
Why?
|
Mouth Mucosa | 1 | 1998 | 437 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1207 | 0.130 |
Why?
|
Medically Uninsured | 1 | 2021 | 841 | 0.130 |
Why?
|
Radiographic Image Enhancement | 1 | 2000 | 877 | 0.130 |
Why?
|
Pneumonectomy | 1 | 2003 | 1158 | 0.130 |
Why?
|
Tongue | 1 | 2019 | 406 | 0.130 |
Why?
|
Prostaglandin D2 | 1 | 2015 | 108 | 0.130 |
Why?
|
Patient Care Team | 1 | 2007 | 2529 | 0.130 |
Why?
|
Galectins | 1 | 2018 | 296 | 0.120 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6856 | 0.120 |
Why?
|
Disease Progression | 4 | 2018 | 13646 | 0.120 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6567 | 0.120 |
Why?
|
Cysts | 1 | 2000 | 685 | 0.120 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2018 | 547 | 0.120 |
Why?
|
Respiratory Mucosa | 1 | 2018 | 439 | 0.120 |
Why?
|
Skull Base Neoplasms | 1 | 1998 | 281 | 0.120 |
Why?
|
Biological Products | 1 | 2024 | 934 | 0.120 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2019 | 465 | 0.120 |
Why?
|
Head | 1 | 2000 | 927 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2168 | 0.120 |
Why?
|
Collagen | 1 | 2003 | 2646 | 0.120 |
Why?
|
Anesthesiology | 1 | 2004 | 1137 | 0.110 |
Why?
|
Noise | 1 | 2016 | 292 | 0.110 |
Why?
|
Mouth | 1 | 2017 | 383 | 0.110 |
Why?
|
Immunoglobulin E | 1 | 2020 | 1506 | 0.110 |
Why?
|
Evidence-Based Medicine | 4 | 2016 | 3707 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2127 | 0.110 |
Why?
|
Pain | 1 | 2008 | 5103 | 0.110 |
Why?
|
Huntington Disease | 1 | 2000 | 1147 | 0.110 |
Why?
|
Urban Health Services | 1 | 2014 | 177 | 0.110 |
Why?
|
Anesthesia | 1 | 2004 | 1596 | 0.110 |
Why?
|
Hemoglobin SC Disease | 1 | 1993 | 23 | 0.110 |
Why?
|
Cell Count | 2 | 2007 | 1833 | 0.110 |
Why?
|
Dinoprostone | 1 | 2016 | 597 | 0.100 |
Why?
|
Stroke | 1 | 2015 | 9742 | 0.100 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 1997 | 342 | 0.100 |
Why?
|
Embolization, Therapeutic | 2 | 2002 | 1410 | 0.100 |
Why?
|
Biopsy, Needle | 4 | 2007 | 1627 | 0.100 |
Why?
|
Polyps | 1 | 2014 | 200 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 1 | 2008 | 3200 | 0.100 |
Why?
|
Statistics as Topic | 3 | 2016 | 2363 | 0.100 |
Why?
|
Mandibular Neoplasms | 1 | 2013 | 131 | 0.100 |
Why?
|
Myringoplasty | 1 | 2011 | 12 | 0.100 |
Why?
|
Ablation Techniques | 1 | 2015 | 255 | 0.100 |
Why?
|
Blood Component Transfusion | 1 | 1993 | 141 | 0.100 |
Why?
|
Aging | 1 | 2011 | 8764 | 0.100 |
Why?
|
Labyrinth Diseases | 1 | 2013 | 151 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2017 | 9433 | 0.100 |
Why?
|
Amoxicillin | 1 | 2013 | 182 | 0.100 |
Why?
|
Polysaccharides | 1 | 2018 | 1024 | 0.100 |
Why?
|
Parent-Child Relations | 1 | 2016 | 774 | 0.090 |
Why?
|
Leukocyte Count | 3 | 2015 | 1605 | 0.090 |
Why?
|
Signal Transduction | 4 | 2025 | 23631 | 0.090 |
Why?
|
Pregnadienediols | 1 | 2011 | 9 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1447 | 0.090 |
Why?
|
Group Practice | 1 | 2012 | 151 | 0.090 |
Why?
|
Interleukin-5 | 2 | 2023 | 267 | 0.090 |
Why?
|
Cholelithiasis | 1 | 1993 | 408 | 0.090 |
Why?
|
Voice | 1 | 2014 | 268 | 0.090 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1672 | 0.090 |
Why?
|
Respiration Disorders | 1 | 2014 | 366 | 0.090 |
Why?
|
Relative Value Scales | 1 | 2011 | 86 | 0.090 |
Why?
|
Boston | 4 | 2016 | 9371 | 0.090 |
Why?
|
Rural Health Services | 1 | 2014 | 393 | 0.090 |
Why?
|
Cholecystectomy | 1 | 1993 | 409 | 0.090 |
Why?
|
Leukotrienes | 1 | 2012 | 232 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 1993 | 236 | 0.090 |
Why?
|
Histamine Antagonists | 1 | 2010 | 94 | 0.090 |
Why?
|
Professional Practice | 1 | 2012 | 314 | 0.090 |
Why?
|
Consensus | 2 | 2021 | 3212 | 0.090 |
Why?
|
Double-Blind Method | 4 | 2011 | 12456 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2025 | 11668 | 0.090 |
Why?
|
Catheter Ablation | 1 | 2003 | 2776 | 0.090 |
Why?
|
Utilization Review | 1 | 2011 | 384 | 0.080 |
Why?
|
Perception | 1 | 2016 | 1205 | 0.080 |
Why?
|
Sulfur Dioxide | 1 | 2010 | 178 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2913 | 0.080 |
Why?
|
Mucociliary Clearance | 1 | 2009 | 81 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2020 | 4875 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2016 | 1309 | 0.080 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2010 | 172 | 0.080 |
Why?
|
Body Mass Index | 2 | 2020 | 13052 | 0.080 |
Why?
|
Internship and Residency | 2 | 2011 | 5949 | 0.080 |
Why?
|
Sensitivity and Specificity | 5 | 2006 | 14737 | 0.080 |
Why?
|
Bronchitis | 1 | 2009 | 196 | 0.080 |
Why?
|
Nurse Practitioners | 1 | 2012 | 271 | 0.080 |
Why?
|
Emergency Medical Services | 2 | 2011 | 1946 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2544 | 0.080 |
Why?
|
Interleukin-13 | 2 | 2023 | 391 | 0.080 |
Why?
|
Bibliometrics | 1 | 2012 | 355 | 0.080 |
Why?
|
Thinking | 1 | 2011 | 320 | 0.070 |
Why?
|
Cranial Fossa, Anterior | 1 | 2007 | 13 | 0.070 |
Why?
|
Drug-Eluting Stents | 2 | 2011 | 681 | 0.070 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4570 | 0.070 |
Why?
|
Audiometry | 1 | 2008 | 253 | 0.070 |
Why?
|
Cranial Fossa, Middle | 1 | 2007 | 29 | 0.070 |
Why?
|
Sarcoma | 2 | 2013 | 1807 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2000 | 4414 | 0.070 |
Why?
|
Ethanol | 1 | 2014 | 1332 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2008 | 198 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2010 | 20224 | 0.070 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1905 | 0.070 |
Why?
|
Seizures | 2 | 2011 | 3000 | 0.070 |
Why?
|
Registries | 4 | 2011 | 8379 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 4 | 2010 | 36849 | 0.070 |
Why?
|
Actuarial Analysis | 1 | 2007 | 372 | 0.070 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2008 | 287 | 0.070 |
Why?
|
Cysteine | 1 | 2012 | 895 | 0.070 |
Why?
|
Nitrogen Dioxide | 1 | 2010 | 527 | 0.070 |
Why?
|
Interleukin-4 | 2 | 2023 | 1157 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2337 | 0.070 |
Why?
|
Carbon Monoxide | 1 | 2010 | 552 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3766 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4266 | 0.070 |
Why?
|
Anesthesia Recovery Period | 1 | 2007 | 155 | 0.070 |
Why?
|
Bacteria, Aerobic | 1 | 2005 | 24 | 0.070 |
Why?
|
Databases as Topic | 1 | 2008 | 475 | 0.060 |
Why?
|
Pediatrics | 2 | 2017 | 3624 | 0.060 |
Why?
|
Causality | 1 | 2012 | 1255 | 0.060 |
Why?
|
Cytokines | 2 | 2024 | 7445 | 0.060 |
Why?
|
Analgesics | 1 | 2013 | 1070 | 0.060 |
Why?
|
Sick Leave | 1 | 2006 | 105 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5800 | 0.060 |
Why?
|
Respiratory Aspiration | 1 | 2007 | 89 | 0.060 |
Why?
|
Bacteria, Anaerobic | 1 | 2005 | 71 | 0.060 |
Why?
|
Particle Size | 1 | 2010 | 1653 | 0.060 |
Why?
|
Antigens, CD34 | 1 | 2008 | 656 | 0.060 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 1486 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2012 | 14784 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3539 | 0.060 |
Why?
|
Social Behavior | 1 | 2012 | 1146 | 0.060 |
Why?
|
Fibroblasts | 1 | 2016 | 4177 | 0.060 |
Why?
|
Cathepsin G | 1 | 2025 | 41 | 0.060 |
Why?
|
Lymph Nodes | 3 | 2005 | 3471 | 0.060 |
Why?
|
Chymases | 1 | 2025 | 84 | 0.060 |
Why?
|
Needs Assessment | 1 | 2011 | 1142 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4785 | 0.060 |
Why?
|
Cell Nucleus | 2 | 2018 | 2886 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5538 | 0.060 |
Why?
|
Educational Status | 1 | 2012 | 2518 | 0.060 |
Why?
|
Radiotherapy Dosage | 2 | 2005 | 2922 | 0.060 |
Why?
|
Neutrophils | 2 | 2007 | 3785 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 504 | 0.060 |
Why?
|
Matched-Pair Analysis | 1 | 2005 | 286 | 0.060 |
Why?
|
Methods | 1 | 2004 | 1067 | 0.060 |
Why?
|
Immunocompromised Host | 1 | 2009 | 863 | 0.060 |
Why?
|
Melanoma | 2 | 2003 | 5705 | 0.060 |
Why?
|
Cell Proliferation | 4 | 2023 | 10478 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 829 | 0.060 |
Why?
|
Nasal Decongestants | 1 | 2003 | 29 | 0.060 |
Why?
|
Hearing Aids | 1 | 2004 | 58 | 0.060 |
Why?
|
Vocal Cords | 3 | 2002 | 520 | 0.060 |
Why?
|
Antibody-Producing Cells | 1 | 2023 | 140 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2030 | 0.060 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2011 | 1422 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2024 | 19022 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2007 | 1585 | 0.050 |
Why?
|
Leukotriene E4 | 2 | 2014 | 75 | 0.050 |
Why?
|
Manikins | 1 | 2004 | 254 | 0.050 |
Why?
|
Diagnosis-Related Groups | 1 | 2004 | 448 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2007 | 442 | 0.050 |
Why?
|
Injections | 2 | 2003 | 840 | 0.050 |
Why?
|
Retreatment | 1 | 2004 | 600 | 0.050 |
Why?
|
Rheology | 1 | 2003 | 348 | 0.050 |
Why?
|
Staphylococcus | 1 | 2002 | 146 | 0.050 |
Why?
|
Physical Examination | 1 | 2008 | 1262 | 0.050 |
Why?
|
Hypopharynx | 1 | 2002 | 53 | 0.050 |
Why?
|
Privacy | 1 | 2004 | 233 | 0.050 |
Why?
|
Hospital Information Systems | 1 | 2004 | 394 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13697 | 0.050 |
Why?
|
Silicones | 1 | 2003 | 228 | 0.050 |
Why?
|
Health Status | 1 | 2015 | 4094 | 0.050 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 1132 | 0.050 |
Why?
|
Goiter | 1 | 2002 | 87 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2001 | 6241 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2012 | 2139 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2023 | 458 | 0.050 |
Why?
|
Inflammation | 3 | 2025 | 10863 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2016 | 4528 | 0.050 |
Why?
|
Equipment Contamination | 1 | 2002 | 183 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2038 | 0.050 |
Why?
|
Blood Platelets | 1 | 2012 | 2476 | 0.050 |
Why?
|
Cause of Death | 1 | 2011 | 3728 | 0.050 |
Why?
|
Equipment Design | 2 | 2011 | 3529 | 0.050 |
Why?
|
Iatrogenic Disease | 1 | 2004 | 552 | 0.050 |
Why?
|
Larynx | 2 | 2002 | 492 | 0.040 |
Why?
|
Blood Loss, Surgical | 1 | 2004 | 643 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2003 | 993 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11120 | 0.040 |
Why?
|
Heart Diseases | 1 | 2013 | 2819 | 0.040 |
Why?
|
Pneumonia | 2 | 2003 | 2163 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2001 | 402 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2007 | 984 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2005 | 971 | 0.040 |
Why?
|
Adenolymphoma | 1 | 1999 | 11 | 0.040 |
Why?
|
Peritonsillar Abscess | 1 | 1999 | 18 | 0.040 |
Why?
|
N-Acetylhexosaminyltransferases | 1 | 2018 | 5 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 838 | 0.040 |
Why?
|
Papilloma, Inverted | 1 | 1998 | 19 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2001 | 784 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2005 | 1274 | 0.040 |
Why?
|
Amino Sugars | 1 | 2018 | 39 | 0.040 |
Why?
|
Physicians | 2 | 2011 | 4614 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2018 | 121 | 0.040 |
Why?
|
Poverty | 1 | 2010 | 2721 | 0.040 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 1 | 2018 | 57 | 0.040 |
Why?
|
Pain Measurement | 1 | 2008 | 3581 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 2533 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4921 | 0.040 |
Why?
|
Particulate Matter | 1 | 2010 | 2609 | 0.040 |
Why?
|
Wood | 1 | 1998 | 92 | 0.040 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2018 | 175 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2001 | 659 | 0.040 |
Why?
|
Professional Competence | 1 | 2001 | 430 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2005 | 1429 | 0.040 |
Why?
|
Health Resources | 1 | 2004 | 950 | 0.040 |
Why?
|
Myasthenia Gravis | 1 | 2000 | 217 | 0.040 |
Why?
|
Osseointegration | 1 | 1999 | 277 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2635 | 0.040 |
Why?
|
Tympanic Membrane | 1 | 1999 | 232 | 0.040 |
Why?
|
Eye Enucleation | 1 | 1997 | 128 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2007 | 2846 | 0.030 |
Why?
|
India | 2 | 2001 | 2325 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1669 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2003 | 913 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2018 | 446 | 0.030 |
Why?
|
Hemangioma | 1 | 2002 | 727 | 0.030 |
Why?
|
Botulinum Toxins, Type A | 1 | 2000 | 238 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2005 | 3633 | 0.030 |
Why?
|
Plasma Cells | 1 | 2020 | 599 | 0.030 |
Why?
|
Prostaglandins D | 1 | 2015 | 27 | 0.030 |
Why?
|
Virginia | 1 | 2016 | 115 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3267 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2018 | 539 | 0.030 |
Why?
|
Germinal Center | 1 | 2018 | 380 | 0.030 |
Why?
|
Penicillins | 1 | 1999 | 406 | 0.030 |
Why?
|
Reference Values | 1 | 2003 | 4941 | 0.030 |
Why?
|
Etoposide | 1 | 1997 | 639 | 0.030 |
Why?
|
Hyperplasia | 1 | 2018 | 1153 | 0.030 |
Why?
|
Specialization | 1 | 2000 | 781 | 0.030 |
Why?
|
Esophagus | 1 | 2001 | 1042 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2002 | 835 | 0.030 |
Why?
|
Veins | 1 | 1999 | 768 | 0.030 |
Why?
|
Haplotypes | 1 | 2000 | 2724 | 0.030 |
Why?
|
Arteries | 1 | 1999 | 1126 | 0.030 |
Why?
|
Endocytosis | 1 | 2018 | 959 | 0.030 |
Why?
|
Massachusetts | 1 | 2007 | 8902 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2018 | 739 | 0.030 |
Why?
|
Arteriovenous Malformations | 1 | 1997 | 396 | 0.030 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2014 | 87 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3827 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8051 | 0.030 |
Why?
|
Clinical Competence | 1 | 2009 | 4848 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2005 | 2909 | 0.030 |
Why?
|
Treatment Failure | 1 | 1999 | 2663 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1053 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2004 | 1937 | 0.030 |
Why?
|
Drainage | 1 | 1999 | 1184 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2007 | 3922 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5878 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2002 | 2708 | 0.030 |
Why?
|
Alleles | 2 | 2001 | 6892 | 0.030 |
Why?
|
Kidney | 1 | 2008 | 7064 | 0.020 |
Why?
|
Hypertension | 1 | 2012 | 8615 | 0.020 |
Why?
|
Research | 1 | 2001 | 1981 | 0.020 |
Why?
|
Graft Survival | 1 | 2003 | 3900 | 0.020 |
Why?
|
Antibodies | 1 | 2020 | 2425 | 0.020 |
Why?
|
Nasal Sprays | 1 | 2011 | 27 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2276 | 0.020 |
Why?
|
Software | 1 | 2006 | 4453 | 0.020 |
Why?
|
Forecasting | 1 | 2001 | 2948 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2018 | 1374 | 0.020 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2012 | 128 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3610 | 0.020 |
Why?
|
Bronchoconstriction | 1 | 2012 | 141 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2003 | 2400 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 775 | 0.020 |
Why?
|
Cisplatin | 1 | 1997 | 1661 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 2011 | 297 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2021 | 5900 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3112 | 0.020 |
Why?
|
Headache | 1 | 1998 | 1262 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4250 | 0.020 |
Why?
|
Granulocytes | 1 | 2012 | 550 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 2011 | 223 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2014 | 702 | 0.020 |
Why?
|
Graft Rejection | 1 | 2003 | 4505 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2011 | 584 | 0.020 |
Why?
|
Sleep Deprivation | 1 | 2016 | 848 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 4775 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1597 | 0.020 |
Why?
|
Debridement | 1 | 2011 | 492 | 0.020 |
Why?
|
Absorbable Implants | 1 | 2011 | 339 | 0.020 |
Why?
|
Education, Medical | 1 | 2000 | 1742 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4300 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5496 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8326 | 0.020 |
Why?
|
Integrins | 1 | 2012 | 843 | 0.020 |
Why?
|
Biopsy | 1 | 1999 | 6808 | 0.020 |
Why?
|
Image Enhancement | 1 | 1997 | 2894 | 0.020 |
Why?
|
Mice | 2 | 2024 | 82017 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9343 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1351 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2592 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7599 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5801 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 15597 | 0.010 |
Why?
|
Patient Care | 1 | 2009 | 629 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10776 | 0.010 |
Why?
|
Barium Sulfate | 1 | 2002 | 180 | 0.010 |
Why?
|
Inhalation | 1 | 2002 | 145 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9493 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4421 | 0.010 |
Why?
|
Animals | 2 | 2024 | 169337 | 0.010 |
Why?
|
Erythema | 1 | 2002 | 261 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12805 | 0.010 |
Why?
|
Pharynx | 1 | 2002 | 436 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 2763 | 0.010 |
Why?
|
Wound Healing | 1 | 2011 | 2813 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 2000 | 556 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2001 | 663 | 0.010 |
Why?
|
Edema | 1 | 2002 | 766 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11918 | 0.010 |
Why?
|
Long-Term Care | 1 | 2000 | 632 | 0.010 |
Why?
|
Observer Variation | 1 | 2002 | 2623 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 11854 | 0.010 |
Why?
|
Communication | 1 | 2009 | 3912 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2009 | 4339 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4622 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 6085 | 0.010 |
Why?
|
Contrast Media | 1 | 2002 | 5336 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2001 | 6971 | 0.000 |
Why?
|